Anxiety Symptoms, Depressive Symptoms
Conditions
Keywords
Randomized Controlled Trial, Cognitive Behavioural Therapy, Youths, Depressive and Anxiety Symptoms
Brief summary
The proposed study is a randomized controlled trial (RCT) that aims to examine the effectiveness of cognitive behavioural therapy in reducing depressive and anxiety symptoms for youths in Hong Kong. It is to be carried out with 120 youths aged 12 - 24 recruited from a series of community-based LevelMind@JC hubs, funded by the Hong Kong Jockey Club Charities Trust. It is designed to improve the youths' abilities/ skills in handling moods to have better emotional management. A written informed consent will be signed by participants. Researchers will perform cognitive behavioural therapy on youths who agree to join the study.
Interventions
CBT is a well-established, evidence-based intervention frequently used for easing depressive and anxiety symptoms. The intervention will be delivered for 6-7 sessions, each session lasts for 1.5 hours, in the format of a group for a period of 6-7 weeks by frontline social or youth workers trained by professional CBT clinicians. Core treatment components include mood monitoring, emotion education, behavioural activation, emotion cycle/ ABC model, identification of automatic thoughts, and cognitive restructuring. It is designed to improve youths' abilities/ skills in handling their moods to have better emotional management.
Sponsors
Study design
Eligibility
Inclusion criteria
* LevelMind@JC users with mild to moderate distress level (n=120); * have sufficient proficiency in Chinese to understand verbal instructions and give informed consent;
Exclusion criteria
* known diagnosis of intellectual disability * organic brain disorder * photosensitive epilepsy * significant visual, auditory or balance impairment * current or previous use of illicit drugs * known psychiatric diagnosis (stabilized diagnosis and treatment) * receiving any psychosocial treatment for social withdrawal such as CBT or; * current or active suicidal ideation or attempts.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in depressive and anxiety levels | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Depression Anxiety Stress Scales (DASS), scores ranging from 0-42 for each subscale, with higher scores representing worse outcome |
| Change in social anxiety levels | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Social Interaction Anxiety Scale (SIAS), scores ranging from 0-80 with higher scores representing higher levels of social anxiety hence worse outcome |
| Change in depressive levels | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Patient Health Questionnaire-9 (PHQ-9), scores ranging from 0-27 with higher scores representing higher depressive levels hence worse outcome |
| Change in distress levels | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Kessler Psychological Distress Scale (K6), scores ranging from 0-25 with higher scores representing higher distress hence worse outcome |
| Change in depressive symptoms | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Beck Depression Inventory II (BDI-II), scores ranging from 0-63 with higher scores representing severe depressive symptoms hence worse outcome |
| Change in anxiety symptoms | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Beck Anxiety Inventory (BAI), scores ranging from 0-36 with higher scores representing severe anxiety symptoms hence worse outcome |
| Change in anxiety levels | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Generalized Anxiety Stress Scale-7 (GAD-7), scores ranging from 0-21 with higher scores representing higher anxiety levels hence worse outcome |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in self-esteem | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Rosenberg Self Esteem Scale (RSE), scores ranging from 0-30 with higher scores indicating higher self-esteem |
| Change in mindfulness | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Mindful Attention Awareness Scale (MAAS), scores ranging from 1-6 with higher scores indicating higher mindful awareness |
| Change in functioning | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Role Functioning Scale (RFS), scores ranging from 1-28 with higher scores representing better functioning |
| Change in social and occupational functioning | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Social and Occupational Functioning Assessment Scale (SOFAS), scores ranging from 0-100 with higher scores representing better functioning |
| Change in quality of life | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | 12-item Short Form Survey (SF-12), scores ranging from 0-100 with higher scores representing better quality of life |
| Change in self-harm | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Self-harming behaviour, plans and thoughts, recording as binary response (0=No, 1=Yes) |
| Change in resilience | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Connor-Davidson Resilience Scale (CD-RISC), scores ranging from 0-100 with higher scores indicating higher resilience |
| Change in future outlook | Baseline, after 7 weeks of intervention/wait, and 1 month after post-intervention | Future Outlook Inventory (FOI), scores ranging from 1-70 with higher scores indicating greater degree of future consideration |
Countries
Hong Kong